Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

AYTU AYTU BioPharma Inc

1,38

0,00 (0,00%)

21 Dez 2024 - Geschlossen

Verzögert um 15 Minuten

Form 3 - Initial statement of beneficial ownership of securities

AYTU BioPharma (NASDAQ:AYTU)
Historical Stock Chart
Von Nov 2024 bis Dez 2024

Click Here for more AYTU BioPharma Charts.

AYTU BioPharma (NASDAQ:AYTU)
Historical Stock Chart
Von Dez 2023 bis Dez 2024

Click Here for more AYTU BioPharma Charts.

News AYTU BioPharma Inc

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Mittwoch 13 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mittwoch 13 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Mittwoch 13 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 9 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 9 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 9 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 9 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 9 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 9 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
Freitag 11 Oktober 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 2 Oktober 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 1 Oktober 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere AYTU BioPharma Inc News-Artikel

Deutsche Telekom (QX)

Deutsche Telekom

Financial Select Sector

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen